A detailed history of Wsfs Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wsfs Capital Management, LLC holds 6,848 shares of ABBV stock, worth $1.23 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,848
Previous 6,412 6.8%
Holding current value
$1.23 Million
Previous $1.1 Million 23.02%
% of portfolio
0.07%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $71,434 - $86,907
436 Added 6.8%
6,848 $1.35 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $1.34 Million - $1.56 Million
-8,651 Reduced 57.43%
6,412 $1.1 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $1.39 Million - $1.58 Million
8,673 Added 135.73%
15,063 $2.74 Million
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $34,124 - $38,432
-248 Reduced 3.74%
6,390 $990,000
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $625,735 - $724,380
4,684 Added 239.71%
6,638 $989,000
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $54,329 - $67,609
-410 Reduced 17.34%
1,954 $263,000
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $263,479 - $303,435
-1,822 Reduced 43.53%
2,364 $376,000
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $169,014 - $202,693
1,222 Added 41.23%
4,186 $676,000
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $15,970 - $18,317
119 Added 4.18%
2,964 $398,000
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $85,324 - $108,475
-620 Reduced 17.89%
2,845 $436,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $457,310 - $567,393
3,465 New
3,465 $562,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $199,712 - $226,704
-1,877 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $9,363 - $10,431
-89 Reduced 4.53%
1,877 $211,000
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $201,121 - $221,410
1,966 New
1,966 $213,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wsfs Capital Management, LLC Portfolio

Follow Wsfs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wsfs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wsfs Capital Management, LLC with notifications on news.